Chad vs Georgia: Access to anti-retroviral drugs, female
Chad
72.0%
in 2024
Georgia
72.0%
in 2024
Chad rank
76th
Georgia rank
76th
Access to anti-retroviral drugs, female over time
- Chad
- Georgia
How they compare
Chad currently reports 72.0% against 72.0% in Georgia, a difference of 0.0%.
Across all 25 years both countries report, Georgia has been ahead every year.
Chad ranks 76th and Georgia ranks 76th of 141 countries.
Georgia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chad | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.0% | 12.0% | 7.0% | Georgia |
| 2010s | 37.4% | 62.0% | 24.6% | Georgia |
| 2020s | 62.8% | 74.8% | 12.0% | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Chad or Georgia?
- Chad, at 72.0% against 72.0% in Georgia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Chad and Georgia?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Georgia?
- 25 years are reported by both, from 2000 to 2024.
- How do Chad and Georgia rank globally for access to anti-retroviral drugs, female?
- Chad ranks 76th and Georgia ranks 76th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.